Nexus AG

ETR-NXU
Deutsche Börse Xetra NYSE
Healthcare Health Information Services
Global Rank
#7551
Country Rank
#139
Market Cap
1.43 B
Price
82.85
Change (%)
0.69%
Volume
77

Nexus AG's latest marketcap:

1.43 B

As of 06/09/2025, Nexus AG's market capitalization has reached $1.43 B. According to our data, Nexus AG is the 7551th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 1.43 B
Revenue (ttm) 311.05 M
Net Income (ttm) 37.07 M
Shares Out 17.24 M
EPS (ttm) 2.15
Forward PE 0.00
Ex-Dividend Date 05/23/2025
Earnings Date 05/20/2025
Market Cap Chart
Data Updated: 06/09/2025

Nexus AG's yearly market capitalization.

Nexus AG has seen its market value grow from €803.02 M to €1.25 B since 2020, representing a total increase of 55.84% and an annual compound growth rate (CAGR) of 10.50%.
Date Market Cap Change (%)
06/09/2025 €1.25 B 4.74%
12/30/2024 €1.19 B 19.14%
12/29/2023 €1 B 4.2%
12/30/2022 €962.29 M -14.63%
12/30/2021 €1.13 B 40.37%
12/30/2020 €803.02 M

Company Profile

About Nexus AG

Nexus AG is a leading provider of software solutions for the healthcare sector, operating in Germany, Switzerland, Liechtenstein, the Netherlands, Poland, France, Austria, and internationally. Founded in 1989 and headquartered in Donaueschingen, Germany, the company specializes in innovative healthcare IT systems.

Business Segments

The company operates through three key segments:

  • NEXUS / DE
  • NEXUS / DIS
  • NEXUS / ROE

Key Solutions & Offerings

Nexus AG provides a comprehensive suite of healthcare IT solutions, including:

  • Hospital Information Systems: Mobile solutions, digital charts, medication management, PDMS, and device connectivity.
  • Diagnostics Solutions: Human genetics, molecular pathology, specialized laboratories, gynecology, ophthalmology, and advanced reporting.
  • Radiology & VNA Solutions: RIS, PACS, teleradiology portals, telemedicine networking, and DICOM RT-viewer.
  • Pathology & Laboratory Solutions: Integrated IT services for pathology, cytology, and diagnostics.
  • Residential & Psychiatry Solutions: Tailored software for care facilities and mental health institutions.

Additional Services

The company also offers patient portals, emergency management, medical archives, and referral portals to enhance healthcare delivery.

Frequently Asked Questions

  • What is Nexus AG's (ETR-NXU) current market cap?
    As of 06/09/2025, Nexus AG (including the parent company, if applicable) has an estimated market capitalization of $1.43 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Nexus AG global market capitalization ranking is approximately 7551 as of 06/09/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.